Leerink Partnrs Issues Positive Estimate for AMLX Earnings
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Free Report) – Equities research analysts at Leerink Partnrs upped their Q1 2025 EPS estimates for shares of Amylyx Pharmaceuticals in a research report issued on Tuesday, May 6th. Leerink Partnrs analyst M. Goodman now anticipates that the company will post earnings of ($0.47) per share for the quarter, up […]
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Free Report) – Equities research analysts at Leerink Partnrs upped their Q1 2025 EPS estimates for shares of Amylyx Pharmaceuticals in a research report issued on Tuesday, May 6th. Leerink Partnrs analyst M. Goodman now anticipates that the company will post earnings of ($0.47) per share for the quarter, up […]
